Subscribe
shutterstock_1123869875-servickuz
Servickuz / Shutterstock.com
27 October 2020BiotechnologyJoachim Wachenfeld and Florian Grasser

A stricter interpretation: the EPO and antibodies

The invention of the antibody hybridoma technology by Nobel prize winners Georges Köhler and César Milstein in 1975 paved the way to the development of therapeutic antibodies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
EPO’s new examination guidelines: what you need to know
6 April 2021   The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.
Big Pharma
Medical tech leads 2020 innovation at the EPO
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Americas
Danish university sues Creative Biolabs over ‘antibody pirating’
9 December 2020   The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Biotechnology
EPO’s new examination guidelines: what you need to know
6 April 2021   The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.
Big Pharma
Medical tech leads 2020 innovation at the EPO
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Americas
Danish university sues Creative Biolabs over ‘antibody pirating’
9 December 2020   The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5.

More on this story

Biotechnology
EPO’s new examination guidelines: what you need to know
6 April 2021   The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.
Big Pharma
Medical tech leads 2020 innovation at the EPO
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Americas
Danish university sues Creative Biolabs over ‘antibody pirating’
9 December 2020   The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5.

More features

Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Broad Institute wins appeal to restore CRISPR patent in Europe